News | Radiation Therapy | October 29, 2015

Brainlab Showcases Next-Gen Cranial Radiosurgery Software at ASTRO 2015

Indication-specific Elements software modules aim to optimize existing treatment processes for stereotactic radiosurgery

Brainlab, cranial Elements for stereotactic radiosurgery, SRS, ASTRO 2015, VMAT, dynamic conformal arcs

October 29, 2015 — Brainlab showcased cranial Elements for stereotactic radiosurgery (SRS) at the 57th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Dovetailing with the society’s 2015 theme, “Technology Meets Patient Care,” Elements provide indication-specific and intelligent workflows for stereotactic radiosurgery that automate the procedure so caregivers can spend more time with patients and less time on technology.

With Elements, Brainlab has identified, extracted and refined valuable, clinician-preferred features and benefits from iPlan and developed à la carte modules offered in a wide range of business models.

Elements Cranial SRS will become the core treatment software that complements existing workflows and will help overcome challenges and limitations in the industry. This software toolkit will enhance virtually every department’s workflows. Every step of the process, every software screen in Elements SRS will be based on clinical need and user necessity – doctor-patient interaction need not be compromised or shortened by cumbersome technological requirements.

Dynamic conformal arcs have been extremely successful over the past two decades, used to deliver millions of treatments because they are dosimetrically easy to validate and are dosimetrically robust in the planning and delivery process. Nevertheless, the increased flexibility in shaping the dose using volumetric modulated arc therapy (VMAT) techniques has also become attractive.

The software is offered in different business models including subscriptions, according to Sean Clark, Brainlab Inc. president. He said that this format allows facilities to cost-effectively invest in future innovations and capitalize on premium features as they are introduced.

For more information: www.brainlab.com

Related Content

Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes

Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes. The metallic-based nanoparticles show up on CT scans so it can be used as a permanent fiduciary marker to track tumor response. The images show the initial tumor and enhancement areas due to the nanoparticles and the resulting outcomes following treatment. Photo by Dave Fornell

Feature | Radiation Oncology | January 30, 2019 | By Dave Fornell
Artificial intelligence (AI) has been the hot topic discussed at all trade shows, and the...